Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The immunogenic peptide for Th1 development.

Kiyoshi Takatsu1, Ai Kariyone

  • 1Division of Immunology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Tokyo 108-8639, Minato, Japan. takatsuk@ims.u-tokyo.ac.jp

International Immunopharmacology
|June 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL-5-producing Group 2 innate lymphoid cells promote T cell-independent IgA production in cooperation with eosinophils.

International immunology·2024
Same author

Isoliquiritigenin inhibits NLRP3 inflammasome activation with CAPS mutations by suppressing caspase-1 activation and mutated NLRP3 aggregation.

Genes to cells : devoted to molecular & cellular mechanisms·2024
Same author

Lung group 2 innate lymphoid cells differentially depend on local IL-7 for their distribution, activation, and maintenance in innate and adaptive immunity-mediated airway inflammation.

International immunology·2023
Same author

Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice.

International journal of molecular sciences·2023
Same author

Roles of Macrophages in Advanced Liver Fibrosis, Identified Using a Newly Established Mouse Model of Diet-Induced Non-Alcoholic Steatohepatitis.

International journal of molecular sciences·2022
Same author

The inflammasomes and immunometabolism: A small molecule inhibitor of the NLRP3 inflammasome.

Biochemical and biophysical research communications·2022
Same journal

Berbamine improves behavioral impairments in Huntington's disease mice models through inhibiting Src/AKT1/NFκB signaling pathway and attenuating Src-mediated mitophagy suppression.

International immunopharmacology·2026
Same journal

Macrophage autophagy in allergic diseases: Regulatory mechanisms, immune crosstalk, and therapeutic implications.

International immunopharmacology·2026
Same journal

ANXA11 recruits tumor-associated neutrophils to promote the progression of colorectal cancer.

International immunopharmacology·2026
Same journal

HO-1 alleviates lipopolysaccharide-induced acute lung injury in mice by downregulating TFE3 expression and nuclear translocation and suppressing Golgi stress response.

International immunopharmacology·2026
Same journal

Corrigendum to "Eicosapentaenoic acid attenuates hyperoxia-induced lung injury via p38 MAPK/NF-κB-mediated regulation of glycolytic reprogramming" [Int. Immunopharmacol. 168(Part 2) (2026) 115903].

International immunopharmacology·2026
Same journal

ENOX1 promotes gastric cancer progression via Snail2-mediated epithelial-mesenchymal transition and M2-type tumour-associated macrophages polarisation.

International immunopharmacology·2026
See all related articles

This study identifies Peptide-25 from Ag85B as a potent "Th1-inducing peptide." It effectively stimulates Th1 cell development and enhances immune responses, offering protection against Mycobacterium tuberculosis infection.

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • T-helper 1 (Th1) cells are crucial for cell-mediated immunity against intracellular pathogens.
  • The specific immunogenic peptides that induce Th1 development and regulate immune responses remain incompletely understood.
  • Ag85B is a highly potent antigen, and its peptide epitope, Peptide-25, has shown promise in eliciting strong Th1 responses.

Purpose of the Study:

  • To investigate the capacity of Ag85B Peptide-25 to induce Th1 cell development.
  • To determine the role of Peptide-25 in regulating immune responses and its potential as a vaccine adjuvant.
  • To propose a designation for Peptide-25 based on its Th1-inducing properties.

Main Methods:

  • Active immunization of C57BL/6 mice with Ag85B Peptide-25 (aa240-254).

Related Experiment Videos

  • Analysis of induced T-helper cell populations (CDT4(+) TCRVbeta11(+) and CDT4(+) TCRVbeta11(-)).
  • Measurement of cytokine production (IFN-gamma, TNF-alpha) and assessment of protection against Mycobacterium tuberculosis H37Rv infection.

    • Main Results:

    • Peptide-25 immunization induced the development of specific Th1 cell subsets.
    • These Th1 cells produced key cytokines, including IFN-gamma and TNF-alpha.
    • Peptide-25 demonstrated significant adjuvant activity, enhancing both humoral and cell-mediated immunity, and conferred protection against M. tuberculosis challenge.

    Conclusions:

    • Ag85B Peptide-25 is a potent inducer of Th1 cell development and function.
    • Peptide-25 possesses significant adjuvant properties, mediated by Th1 cells.
    • The study proposes designating Peptide-25 as a "Th1-inducing peptide" for its immunomodulatory capabilities.